We are live on ! Find out more
UBX

Unity Biotechnology
UBX

Delisted

UBX was delisted on the 8th of July, 2025.

Back to rankings

84 hedge funds and large institutions have $216M invested in Unity Biotechnology in 2020 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 31 increasing their positions, 14 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

25,500% more call options, than puts

Call options by funds: $256K | Put options by funds: $1K

121% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 14

91% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 11

70% more capital invested

Capital invested by funds: $127M → $216M (+$89.3M)

14% more funds holding

Funds holding: 74 → 84 (+10)

0.47% more ownership

Funds ownership: 4.6% → 5.07% (+0.47%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
84
Holders Change
+10
Holders Change %
+13.51%
% of All Funds
1.72%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
21
Increased
31
Reduced
14
Closed
11
Calls
$256K
Puts
$1K
Net Calls
+$255K
Net Calls Change
+$134K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$5.07M
2
Millennium Management
Millennium Management
New York
+$3.72M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$2.58M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.33M
5
MAM
Martingale Asset Management
Massachusetts
+$1.41M

Top Sellers

Rank Fund Capital Flow
1
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$481K
2
Citadel Advisors
Citadel Advisors
Florida
-$413K
3
Cerity Partners
Cerity Partners
New York
-$348K
4
VEA
Virtus ETF Advisers
New York
-$249K
5
MSAM
Moloney Securities Asset Management
Missouri
-$226K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$52.9M +$2.58M +34,833 +6%
Baillie Gifford & Co
2
Baillie Gifford & Co
United Kingdom
$33M – – –
BlackRock
3
BlackRock
New York
$25.1M +$5.07M +68,434 +31%
IFA
4
Invus Financial Advisors
New York
$19M – – –
Capital World Investors
5
Capital World Investors
California
$15.9M – – –
MC
6
Mayo Clinic
Minnesota
$13.6M – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$12.5M +$2.33M +31,440 +28%
State Street
8
State Street
Massachusetts
$5M +$827K +11,159 +24%
Millennium Management
9
Millennium Management
New York
$4.62M +$3.72M +50,128 +1,629%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$4.04M +$474K +6,389 +16%
Northern Trust
11
Northern Trust
Illinois
$3.4M +$457K +6,167 +19%
Renaissance Technologies
12
Renaissance Technologies
New York
$2.44M +$1.01M +13,650 +95%
Jacobs Levy Equity Management
13
Jacobs Levy Equity Management
New Jersey
$2.17M -$481K -6,480 -21%
Russell Investments Group
14
Russell Investments Group
United Kingdom
$1.88M -$48.5K -654 -3%
MAM
15
Martingale Asset Management
Massachusetts
$1.65M +$1.41M +18,972 New
Charles Schwab
16
Charles Schwab
California
$1.64M +$155K +2,095 +13%
Morgan Stanley
17
Morgan Stanley
New York
$1.53M +$861K +11,616 +192%
N
18
Nuveen
North Carolina
$1.38M +$370K +4,993 +46%
Wells Fargo
19
Wells Fargo
California
$1.22M +$884K +11,925 +559%
Citadel Advisors
20
Citadel Advisors
Florida
$1.21M -$413K -5,574 -29%
ACM
21
Asymmetry Capital Management
California
$1.04M +$891K +12,018 New
Bessemer Group
22
Bessemer Group
New Jersey
$914K +$781K +10,530 New
Bank of New York Mellon
23
Bank of New York Mellon
New York
$756K +$50.3K +679 +8%
JP Morgan Chase
24
JP Morgan Chase
New York
$735K +$560K +7,557 +828%
California Public Employees Retirement System
25
California Public Employees Retirement System
California
$578K +$273K +3,675 +123%
1
2 3 4

UBX Hedge Fund Activity: Q2 2020 in Review

84 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Unity Biotechnology (UBX) for Q2 2020, worth a combined $216M — up 70% from $127M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new UBX positions and 11 closed out — a net gain of 10 holders — while 31 added to existing stakes and 14 trimmed.

The largest buyer was BlackRock, adding an estimated $5.07M. The largest seller was Jacobs Levy Equity Management, cutting an estimated $481K.

  • 84 institutional investors held Unity Biotechnology (UBX) as of Q2 2020, up from 74 in Q1 2020.
  • Funds reported $216M of Unity Biotechnology stock for Q2 2020, up 70% quarter-over-quarter.
  • 21 funds opened new Unity Biotechnology positions in Q2 2020 and 11 closed out, a net change of +10 holders.
  • The largest Unity Biotechnology buyer in Q2 2020 was BlackRock, an estimated $5.07M added.
  • The largest Unity Biotechnology seller in Q2 2020 was Jacobs Levy Equity Management, an estimated $481K sold.

Based on aggregated 13F filings for Q2 2020.